PDGF-BB prevents destructive repair and promotes reparative osteogenesis of steroid-associated osteonecrosis of the femoral head in rabbits.
暂无分享,去创建一个
Y. Lai | Xueling Bai | Xinluan Wang | J. Long | Lingli Li | Huijuan Cao | Cuishan Huang | Keda Shi | Ling Qin | Yanzhi Liu | Tianluo Ye
[1] D. Zhao,et al. Relationship Between Blood Flow and Collapse of Nontraumatic Osteonecrosis of the Femoral Head , 2022, The Journal of bone and joint surgery. American volume.
[2] Junjie Niu,et al. Steroid-Induced Osteonecrosis of the Femoral Head: Novel Insight Into the Roles of Bone Endothelial Cells in Pathogenesis and Treatment , 2021, Frontiers in Cell and Developmental Biology.
[3] Yanqiong Zhang,et al. General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19 , 2021, Journal of Orthopaedic Translation.
[4] T. Yuen,et al. The role of PDGF-BB in the bone-vascular relationship during aging. , 2021, The Journal of clinical investigation.
[5] Y. Yang,et al. The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits , 2021, Stem cell research & therapy.
[6] Xu Cao,et al. Skeleton-derived PDGF-BB mediates arterial stiffening. , 2021, The Journal of clinical investigation.
[7] Sakae Tanaka,et al. Femoral head collapse rate among Japanese patients with pre-collapse osteonecrosis of the femoral head , 2021, The Journal of international medical research.
[8] W. Giannobile,et al. Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures , 2020, JDR clinical and translational research.
[9] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[10] S. Demehri,et al. Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. , 2020, JCI insight.
[11] Xu Cao,et al. Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF‐κB–Mediated Preosteoclast Pdgfb Transcription in Young Mice , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] Seung-Jae Lim,et al. Hip resurfacing arthroplasty for osteonecrosis of the femoral head: Implant-specific outcomes and risk factors for failure , 2020, Journal of orthopaedic translation.
[13] Yi-Xian Qin,et al. Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head , 2020, Artificial cells, nanomedicine, and biotechnology.
[14] Yi Peng,et al. Type H blood vessels in bone modeling and remodeling , 2020, Theranostics.
[15] Jiang Peng,et al. Three-dimensional distribution of cystic lesions in osteonecrosis of the femoral head , 2019, Journal of orthopaedic translation.
[16] Wei Sun,et al. The Use of Platelet-Rich Plasma for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review , 2019, BioMed research international.
[17] Yu-Jie Liang,et al. PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis. , 2019, Bone.
[18] Kui Zang,et al. Platelet-derived growth factor B attenuates lethal sepsis through inhibition of inflammatory responses. , 2019, International immunopharmacology.
[19] Shouan Zhu,et al. Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration. , 2019, The Journal of clinical investigation.
[20] Jiang Peng,et al. Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect. , 2019, Biomaterials.
[21] N. Sugano,et al. Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1: Glucocorticoid-Associated Osteonecrosis. , 2019, Journal of Arthroplasty.
[22] J. Urbaniak,et al. Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: An experimental study in canines , 2018, World journal of orthopedics.
[23] Ping Yang,et al. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice. , 2018, Bone.
[24] Dewei Zhao,et al. Early diagnosis and treatment of steroid-induced osteonecrosis of the femoral head , 2018, International Orthopaedics.
[25] J. Griffith,et al. Blockage of Src by Specific siRNA as a Novel Therapeutic Strategy to Prevent Destructive Repair in Steroid‐Associated Osteonecrosis in Rabbits , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] L. Qin,et al. Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis. , 2015, Bone.
[27] Xin-luan Wang,et al. Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview) , 2015, Journal of Orthopaedic Translation.
[28] S. Morrison,et al. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. , 2014, Cell stem cell.
[29] P. Gervois,et al. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. , 2014, Pharmacology & therapeutics.
[30] L. Duong,et al. PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.
[31] Q. Guo,et al. Bone Microstructure and Regional Distribution of Osteoblast and Osteoclast Activity in the Osteonecrotic Femoral Head , 2014, PloS one.
[32] Zi-rong Li,et al. Relationship between preservation of the lateral pillar and collapse of the femoral head in patients with osteonecrosis. , 2014, Orthopedics.
[33] Y. Seol,et al. Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model. , 2013, Tissue engineering. Part A.
[34] B. Masri,et al. Total hip arthroplasty in steroid-induced osteonecrosis: early functional and radiological outcomes. , 2013, Canadian journal of surgery. Journal canadien de chirurgie.
[35] T. Daniels,et al. Effect of Implantation of Augment® Bone Graft on Serum Concentrations of Platelet-Derived Growth Factors: A Pharmacokinetic Study , 2013, Clinical Drug Investigation.
[36] Yuanyuan Zhang,et al. Coadministration of platelet-derived growth factor-BB and vascular endothelial growth factor with bladder acellular matrix enhances smooth muscle regeneration and vascularization for bladder augmentation in a rabbit model. , 2013, Tissue engineering. Part A.
[37] P. Esbrit,et al. Role of angiogenesis on bone formation. , 2012, Histology and histopathology.
[38] L. Snel,et al. Safety of recombinant human platelet-derived growth factor-BB in Augment® Bone Graft , 2012, Journal of tissue engineering.
[39] M. Merchant,et al. Therapeutic angiogenesis due to balanced single‐vector delivery of VEGF and PDGF‐BB , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] E. Raines,et al. History of discovery: platelet-derived growth factor. , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[41] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[42] N. Baldini,et al. Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors , 2011, Acta orthopaedica.
[43] J. Griffith,et al. Continuous occurrence of both insufficient neovascularization and elevated vascular permeability in rabbit proximal femur during inadequate repair of steroid-associated osteonecrotic lesions. , 2009, Arthritis and rheumatism.
[44] N. Sugano,et al. Distribution of TRAP‐positive cells and expression of HIF‐1α, VEGF, and FGF‐2 in the reparative reaction in patients with osteonecrosis of the femoral head , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[45] Y. Ishii,et al. PDGF Receptor β Is a Potent Regulator of Mesenchymal Stromal Cell Function , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] E H Schemitsch,et al. Fracture vascularity and bone healing: a systematic review of the role of VEGF. , 2008, Injury.
[47] Kwang Woo Nam,et al. Fate of untreated asymptomatic osteonecrosis of the femoral head. , 2008, The Journal of bone and joint surgery. American volume.
[48] David J Mooney,et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.
[49] A. Flahault,et al. Corticosteroid‐induced clinical adverse events: frequency, risk factors and patient’s opinion , 2007, The British journal of dermatology.
[50] Jeffrey R Curtis,et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. , 2006, Arthritis and rheumatism.
[51] J. Griffith,et al. Multiple bioimaging modalities in evaluation of an experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone , 2006, Bone.
[52] A. Nogier,et al. Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. , 2004, The Journal of bone and joint surgery. American volume.
[53] Y. Shoenfeld,et al. Pathogenesis and natural history of osteonecrosis. , 2002, Seminars in arthritis and rheumatism.
[54] Gwo‐Jaw Wang,et al. Risk Period for Developing Osteonecrosis of the Femoral Head in Patients on Steroid Treatment , 2002, Clinical Rheumatology.
[55] K. Wakabayashi,et al. Platelet‐Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory Factor , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[56] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[57] H. Plenk,et al. [Pathomorphological aspects and repair mechanisms of femur head necrosis]. , 2000, Der Orthopade.
[58] C. Betsholtz,et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.
[59] A. Reddi,et al. Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. , 1993, The Journal of clinical investigation.